2022
COVID-19 Vaccine Hesitancy and Associated Factors among People with HIV in the United States: Findings from a National Survey
Shrestha R, Meyer JP, Shenoi S, Khati A, Altice FL, Mistler C, Aoun-Barakat L, Virata M, Olivares M, Wickersham JA. COVID-19 Vaccine Hesitancy and Associated Factors among People with HIV in the United States: Findings from a National Survey. Vaccines 2022, 10: 424. PMID: 35335054, PMCID: PMC8949562, DOI: 10.3390/vaccines10030424.Peer-Reviewed Original ResearchCOVID-19 vaccine hesitancyVaccine hesitancySevere COVID-19 diseaseMean timeSample of PWHCells/mm3COVID-19 historyVaccine-related concernsGreater vaccine hesitancyCOVID-19 vaccineCOVID-19COVID-19 diseaseLower vaccine hesitancyCross-sectional online surveyCD4 countAssociated FactorsSide effectsHIVKey populationsPWHMultivariate linear regressionVaccineCOVID-19 epidemicHesitancyMost participants
2021
856. Barriers to PrEP Implementation among Patient-Facing Staff in Three Urban Clinics
Shenoi S, Sideleau R, McKay S, Aoun-Barakat L. 856. Barriers to PrEP Implementation among Patient-Facing Staff in Three Urban Clinics. Open Forum Infectious Diseases 2021, 8: 519-519. DOI: 10.1093/ofid/ofab466.1051.Peer-Reviewed Original ResearchPrEP implementationPrEP uptakeSafety of PrEPQualified health centersLack of insuranceMultidisciplinary team membersDuration of employmentGuidelines/protocolsPrEP efficacyPrEP servicesMedian durationPrEP useUrban clinicPrEP rolloutHealth centersSafety dataProvider trainingPatient outreachSide effectsSystemic barriersMultidisciplinary staffSexual riskPatientsBehavioral interventionsPrescribers